CRISIL Ltd
NSE:CRISIL
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
4 109.0514
6 048
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
CRISIL Ltd
In the bustling milieu of global finance, CRISIL Ltd. stands as a venerable beacon of analytical acumen and market intelligence. Born in India yet globally revered, CRISIL, which initially made its mark through credit ratings, has woven a rich tapestry of services across varied financial landscapes. The core of its strength lies in its proficiency in assessing the creditworthiness of a vast array of entities, ranging from large corporations to intricate structured finance products. By meticulously evaluating the financial health and risk profiles of these entities, CRISIL furnishes investors and stakeholders with the critical insights they require to make informed decisions. This process of rating not only fortifies the trust in financial markets but also underpins the very foundation of investment strategies for institutions and individuals alike.
Beyond credit ratings, CRISIL monetizes its intellectual capital by offering an extensive repertoire of research services and analytics. The company's consulting services are integral, as they assist firms globally in navigating complex regulatory frameworks and optimizing their financial strategies. Through data-driven insights and rigorous market analysis, CRISIL supports clients across sectors, from banking and insurance to infrastructure and technology. Moreover, its foray into data and research subscriptions allows it to delve deeper into the nuances of market behavior and economic trends, offering a rich source of recurring revenue. In essence, CRISIL capitalizes on its decades-long heritage of financial expertise, leveraging its formidable analytical prowess to not only sustain but strategically grow its business amidst the ever-evolving dynamics of the global financial ecosystem.
In the bustling milieu of global finance, CRISIL Ltd. stands as a venerable beacon of analytical acumen and market intelligence. Born in India yet globally revered, CRISIL, which initially made its mark through credit ratings, has woven a rich tapestry of services across varied financial landscapes. The core of its strength lies in its proficiency in assessing the creditworthiness of a vast array of entities, ranging from large corporations to intricate structured finance products. By meticulously evaluating the financial health and risk profiles of these entities, CRISIL furnishes investors and stakeholders with the critical insights they require to make informed decisions. This process of rating not only fortifies the trust in financial markets but also underpins the very foundation of investment strategies for institutions and individuals alike.
Beyond credit ratings, CRISIL monetizes its intellectual capital by offering an extensive repertoire of research services and analytics. The company's consulting services are integral, as they assist firms globally in navigating complex regulatory frameworks and optimizing their financial strategies. Through data-driven insights and rigorous market analysis, CRISIL supports clients across sectors, from banking and insurance to infrastructure and technology. Moreover, its foray into data and research subscriptions allows it to delve deeper into the nuances of market behavior and economic trends, offering a rich source of recurring revenue. In essence, CRISIL capitalizes on its decades-long heritage of financial expertise, leveraging its formidable analytical prowess to not only sustain but strategically grow its business amidst the ever-evolving dynamics of the global financial ecosystem.
Strong Q1 Growth: Crisil reported a 10.2% increase in revenue and about 16% growth in profit before tax and profit after tax for Q1 FY25, driven by robust performance in Ratings and improved margins.
Ratings Outperformance: The Ratings Services segment grew by approximately 32.5% year-on-year in Q1 2025, significantly outperforming industry growth, due to strong demand for high-quality ratings and several large deals.
Global Uncertainty: Management highlighted ongoing global macroeconomic uncertainty, including tariff actions and slower GDP forecasts, but noted resilience across core business areas.
Research Segment Challenges: Research Analytics and Solutions segment saw muted growth due to curtailed discretionary spending by global clients, but margins improved through cost control.
GenAI Adoption: Company is actively investing in and deploying GenAI solutions in both internal processes and client offerings, with early successes in credit assessment and analytics products.
Positive Domestic Outlook: India's GDP is projected to grow at 6.5% in fiscal 2026, with expected tailwinds for bank credit and corporate bond issuances due to policy support and potential rate cuts.
No Forward Guidance: Crisil refrained from providing specific quantitative guidance or disclosing segment-level operational details.